Acetyl L-carnitine for prevention of painful peripheral neuropathy in patients with type 2 diabetes
AssigneeSigma-Tau Industrie Farmaceutiche Riunite S.p.A.
InventorsAntonino Amato, Menotti Calvani
Life of this patent
Estimating the term…
Abstract
Acetyl L-carnitine, or of one of its pharmaceutically acceptable salts, is useful for the prevention of painful peripheral neuropathy in patients suffering from type 2 diabetes, in which symptoms are pain, paraesthesia or hyperaesthesia. The acetyl L-carnitine is administered orally at a dose of at least 3 grams/day.
Claims3
A method for treating and relieving symptoms of diabetic neuropathy in patients affected by type 2 diabetes, comprising administering to a patient in need thereof 3 grams/day of acetyl L-carnitine, or a pharmaceutically acceptable salt thereof for at least 52 weeks in which said symptoms are selected from the group consisting of pain, paraesthesia or hyperaesthesia.
Dependencies are inferred from the claim text.